Cures 2.0 Act [HB-6000]
[Healthcare ]
[Pharmaceuticals ]
[Science ]
[Technology and Innovation ]
[Public Health ]
To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes.
HB-6000: Cures 2.0 Act
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Biotechnology, Horticulture, And Research. on 01/04/2022
Pandemic Cessation Act [HB-6009]
[Public Health ]
[Healthcare ]
[Pharmaceuticals ]
[Disaster Relief ]
To provide that the public health emergency declared with respect to COVID-19 shall terminate on the date on which the Secretary of Health and Human Services approves, or authorizes emergency use of, a drug intended to treat COVID-19.
HB-6009: Pandemic Cessation Act
Sponsored by: Rep. Andy Biggs
Motion To Discharge Committee Filed By Mr. Schweikert. Petition No: 117-11. (discharge Petition Text With Signatures.) on 03/09/2022
SAVE Act Student Assisted Vaccination Effort Act [HB-5699]
[Healthcare ]
[Public Health ]
[Education ]
[Pharmaceuticals ]
To expand the definition of qualified persons for purposes of the Public Readiness and Emergency Preparedness Act to include health professional students.
HB-5699: SAVE Act Student Assisted Vaccination Effort Act
Sponsored by: Rep. Suzanne Bonamici
Referred To The Subcommittee On Health. on 10/25/2021
Medical Marijuana Research Act [HB-5657]
[Cannabis ]
[Healthcare ]
[Pharmaceuticals ]
[Science ]
[Public Health ]
To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes.
HB-5657: Medical Marijuana Research Act
Sponsored by: Rep. Barbara Lee
Received In The Senate. on 04/05/2022
BRAIN Act of 2021 Bringing Regulatory Advances Into Neuroscience Act of 2021 [HB-5435]
[Healthcare ]
[Science ]
[Public Health ]
[Pharmaceuticals ]
To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a Neuroscience Translation Working Group, and for other purposes.
HB-5435: BRAIN Act of 2021 Bringing Regulatory Advances Into Neuroscience Act of 2021
Sponsored by: Rep. Earl Blumenauer
Referred To The Subcommittee On Health. on 10/01/2021
Excellence in Recovery Housing Act [S.2901]
[Healthcare ]
[Housing ]
[Public Health ]
[Mental Health ]
[Human Services ]
A bill to amend title V of the Public Health Service Act to provide for increased oversight of recovery housing, and for other purposes.
S.2901: Excellence in Recovery Housing Act
Sponsored by: Sen. Sheldon Whitehouse
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/29/2021
Reduced Costs and Continued Cures Act [HB-5260]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
HB-5260: Reduced Costs and Continued Cures Act
Sponsored by: Rep. Luis Correa
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 11/01/2022
Reduced Costs and Continued Cures Act of 2021 [HB-5237]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
[Senior Citizens ]
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
HB-5237: Reduced Costs and Continued Cures Act of 2021
Sponsored by: Rep. Luis Correa
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 11/01/2022
HR-589: Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science.
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Health. on 08/18/2021
You have voted HR-589: Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science..
Safe Medicine Act [HB-5003]
[Healthcare ]
[Pharmaceuticals ]
[Defense ]
[Veterans ]
[National Security ]
[Public Health ]
[Trade ]
[Manufacturing ]
[Funding ]
To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
HB-5003: Safe Medicine Act
Sponsored by: Rep. Tim Ryan
Referred To The Subcommittee On Oversight And Investigations. on 09/09/2021
Quit Because of COVID–19 Act [S.2622]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
A bill to amend title XIX and XXI of the Social Security Act to provide coverage of comprehensive tobacco cessation services under such titles, and for other purposes.
S.2622: Quit Because of COVID–19 Act
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Finance. on 08/05/2021
Disease X Act [S.2640]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
A bill to establish a program for developing medical countermeasures for unknown viral threats.
S.2640: Disease X Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 08/05/2021
SR-336: A resolution designating September 15, 2021, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.
Sponsored by: Sen. Susan Collins
Referred To The Committee On The Judiciary. on 08/04/2021
You have voted SR-336: A resolution designating September 15, 2021, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day..